Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

LHX6 is a sensitive methylation marker in head and neck carcinomas

Texto completo
Autor(es):
Estécio, M. R. H. ; Youssef, E. M. ; Rahal, P. ; Fukuyama, E. E. ; Góis-Filho, J. F. ; Maniglia, J. V. ; Goloni-Bertollo, E. M. ; Issa, J-P J. ; Tajara, E. H.
Número total de Autores: 9
Tipo de documento: Artigo Científico
Fonte: Oncogene; v. 25, n. 36, p. 5018-5026, Aug. 2006.
Área do conhecimento: Ciências Biológicas - Genética
Assunto(s):Genética médica   Metilação de DNA   Neoplasias de cabeça e pescoço
Resumo

Head and neck cancer remains a morbid and often fatal disease and at the present time few effective molecular markers have been identified. The purpose of the present work was to identify new molecular markers for head and neck squamous cell carcinoma (HNSCC). We applied methylation-sensitive arbitrarily primed PCR (MS/AP-PCR) to isolate sequences differentially methylated in HNSCC. The most frequently hypermethylated fragment we found maps close to a cytosine guanine dinucleotide (CpG) island on chromosome 9q33.2, and hypermethylation of this CpG island was associated with transcriptional silencing of an alternative transcript of the LHX6 gene. Using combined bisulfite restriction analysis (COBRA), hypermethylation of this fragment was detected in 13 of 14 (92.8%) HNSCC cell lines studied and 21 of 32 (65.6%) primary tumors, whereas little or no methylation was seen in 10 normal oral mucosa samples. We extended this investigation to other cancer cell lines and methylation was found in those derived from colon, breast, leukemia and lung, and methylation was also found in 12/14 primary colon tumors. These findings suggest that differentially methylated (DIME)-6 hypermethylation is a good cancer marker in HNSCC as well as in other kinds of neoplasias and confirm the importance of searching for markers of epigenetic dysregulation in cancer. (AU)

Processo FAPESP: 99/09368-1 - Análise da metilação do DNA em tumores de cabeça e pescoço
Beneficiário:Marcos Roberto Higino Estécio
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 00/12361-8 - Análise da metilação do DNA em sequências ORESTES e em produtos de AP-PCR gerados a partir de tumores de cabeça e pescoço
Beneficiário:Eloiza Helena Tajara da Silva
Linha de fomento: Auxílio à Pesquisa - Regular